Taysha Gene Therapies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2025 | 24.35 M | $79.64 M | -2.67% | 8.17% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 23.56 M | $77.03 M | 0.00% | 7.90% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 21.70 M | $70.96 M | 0.00% | 7.28% |
| MORGAN STANLEY | 11/14/2025 | 19.31 M | $63.14 M | 14.48% | 6.48% |
| BLACKROCK, INC. | 11/12/2025 | 16.36 M | $53.51 M | 23.01% | 5.49% |
| FMR LLC | 11/13/2025 | 14.59 M | $47.72 M | -6.62% | 4.90% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 13.38 M | $43.76 M | 6.32% | 4.49% |
| VANGUARD GROUP INC | 11/07/2025 | 12.85 M | $42.02 M | 17.95% | 4.31% |
| SIREN, L.L.C. | 11/13/2025 | 11.01 M | $36.02 M | 0.00% | 3.70% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 9.07 M | $29.65 M | -27.99% | 3.04% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 7.33 M | $23.97 M | 0.19% | 2.46% |
| STATE STREET CORP | 11/14/2025 | 7.24 M | $23.66 M | 40.83% | 2.43% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 5.50 M | $17.99 M | 83.33% | 1.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 5.39 M | $17.61 M | 0.00% | 1.81% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 5.29 M | $17.31 M | 5.88% | 1.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 5.17 M | $16.92 M | 36.40% | 1.74% |
| BARCLAYS PLC | 11/12/2025 | 5.15 M | $16.83 M | 1,042.75% | 1.73% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 4.03 M | $13.17 M | 37.14% | 1.35% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 4.00 M | $13.10 M | 0.00% | 1.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 11/06/2025 | 3.70 M | $12.10 M | -9.65% | 1.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 3.33 M | $10.88 M | -31.23% | 1.12% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 3.00 M | $9.81 M | 1,400.00% | 1.01% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.84 M | $9.27 M | -5.79% | 0.95% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.71 M | $8.85 M | 574.07% | 0.91% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 2.16 M | $7.05 M | -79.09% | 0.72% |
| TORONTO DOMINION BANK | 11/14/2025 | 1.92 M | $6.29 M | -59.31% | 0.65% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2025 | 1.90 M | $6.21 M | 100.00% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.85 M | $6.04 M | 275.53% | 0.62% |
| B GROUP, INC. | 11/14/2025 | 1.80 M | $5.89 M | 0.00% | 0.60% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.72 M | $5.62 M | 29.23% | 0.58% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 1.50 M | $4.91 M | 0.00% | 0.50% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.31 M | $4.27 M | 78.90% | 0.44% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 1.25 M | $4.07 M | 0.00% | 0.42% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 1.12 M | $3.65 M | 16.50% | 0.37% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 900.00 K | $2.94 M | 0.00% | 0.30% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 839.67 K | $2.75 M | -30.26% | 0.28% |
| QUANTUM PRIVATE WEALTH, LLC | 11/10/2025 | 822.08 K | $2.69 M | 0.75% | 0.28% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2025 | 724.87 K | $2.37 M | 0.00% | 0.24% |
| ALPHABET INC. | 11/07/2025 | 640.88 K | $2.10 M | 0.00% | 0.22% |
| UBS GROUP AG | 11/13/2025 | 639.36 K | $2.09 M | 144.74% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 624.84 K | $2.04 M | 36.23% | 0.21% |
| ANSON FUNDS MANAGEMENT LP | 11/14/2025 | 603.50 K | $1.97 M | -24.89% | 0.20% |
| ROYAL BANK OF CANADA | 11/14/2025 | 583.38 K | $1.91 M | 17.78% | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 578.12 K | $1.89 M | 100.00% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 568.01 K | $1.86 M | -10.69% | 0.19% |
| JANE STREET GROUP, LLC | 11/14/2025 | 556.79 K | $1.82 M | 306.43% | 0.19% |
| NUVEEN, LLC | 11/12/2025 | 507.21 K | $1.66 M | 9.04% | 0.17% |
| WOODLINE PARTNERS LP | 11/14/2025 | 500.00 K | $1.64 M | -50.01% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 477.75 K | $1.56 M | 969.03% | 0.16% |
| MARSHALL WACE, LLP | 11/13/2025 | 476.87 K | $1.56 M | 499.85% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Taysha Gene Therapies, Inc. institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Taysha Gene Therapies, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 24.35 M
RA CAPITAL MANAGEMENT, L.P.: 23.56 M
Avoro Capital Advisors LLC: 21.7 M
MORGAN STANLEY: 19.31 M
BlackRock, Inc.: 16.36 M
FMR LLC: 14.59 M
88.79% of Taysha Gene Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 279.07 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.